TipRanks
Go Ultimate55% OFF

SK Biopharmaceuticals Co., Ltd. (326030) Balance Sheet

SK Biopharmaceuticals Co., Ltd. Balance Sheet

SK Biopharmaceuticals Co., Ltd.'s total assets for Q2 2026 were $1.42T, an increase of 7.45% from the previous quarter. KR:326030 total liabilities were $397.00B for the fiscal quarter, a 2.22% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.20T$ 1.04T$ 723.17B$ 664.24B$ 643.65B
$ 372.04B$ 462.83B$ 402.22B$ 347.68B$ 199.46B
$ 826.27B$ 573.98B$ 320.95B$ 316.56B$ 444.19B

Currency in KRW

SK Biopharmaceuticals Co., Ltd. Debt to Assets

0500B1T1.5T0 %40 %80 %120 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets